← Open Payments lookup

JASON VESTAL: Open Payments

NPI 1851899215 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$174 in 7 payments from 7 companies in 2025. Trend: 2023 $495 · 2024 $174 · 2025 $174

Food & beverage: $174
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.1$43
Alkermes, Inc.1$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Otsuka America Pharmaceutical, Inc.1$25
Janssen Pharmaceuticals, Inc1$22
ABBVIE INC.1$18
E.R. Squibb & Sons, L.L.C.1$18

Products named: UZEDY, ARISTADA, CAPLYTA, REXULTI, INVEGA SUSTENNA, VRAYLAR, COBENFY.

Industry payments across WA — which companies pay providers there.